Citation tools

Hirsh, Andrew J. et al "Pharmacological Properties of N-(3,5-Diamino-6-chloropyrazine-2-carbonyl)-N′-4-[4-(2,3-dihydroxypropoxy)phenyl]butyl-guanidine Methanesulfonate (552-02), a Novel Epithelial Sodium Channel Blocker with Potential Clinical Efficacy for Cystic Fibrosis Lung Disease." Journal of Pharmacology and Experimental Therapeutics 325.1 (2008): 77-88. Web. 27 Jan. 2022.